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Abstract
Somatostatin (somatotropin release inhibiting factor) is an abundant neuropeptide, which acts on five subtypes
of somatostatin receptor (SST1-SST5; nomenclature as agreed by the NC-IUPHAR Subcommittee on
Somatostatin Receptors [89]). Activation of these receptors produces a wide range of physiological effects
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throughout the body including the inhibition of secretion of many hormones. Endogenous ligands for these
receptors are somatostatin-14 (SRIF-14) and somatostatin-28 (SRIF-28). cortistatin-14 has also been suggested
to be an endogenous ligand for somatostatin receptors [56].
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